Prostate Cancer Nuclear Medicine Diagnostics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 SPECT
1.2.3 PET
1.3 Market by Application
1.3.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Perspective (2017-2028)
2.2 Prostate Cancer Nuclear Medicine Diagnostics Growth Trends by Region
2.2.1 Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Prostate Cancer Nuclear Medicine Diagnostics Market Dynamics
2.3.1 Prostate Cancer Nuclear Medicine Diagnostics Industry Trends
2.3.2 Prostate Cancer Nuclear Medicine Diagnostics Market Drivers
2.3.3 Prostate Cancer Nuclear Medicine Diagnostics Market Challenges
2.3.4 Prostate Cancer Nuclear Medicine Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Revenue
3.1.1 Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Nuclear Medicine Diagnostics Revenue
3.4 Global Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio
3.4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2021
3.5 Prostate Cancer Nuclear Medicine Diagnostics Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Nuclear Medicine Diagnostics Product Solution and Service
3.7 Date of Enter into Prostate Cancer Nuclear Medicine Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Nuclear Medicine Diagnostics Breakdown Data by Type
4.1 Global Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Type (2023-2028)
5 Prostate Cancer Nuclear Medicine Diagnostics Breakdown Data by Application
5.1 Global Prostate Cancer Nuclear Medicine Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size (2017-2028)
6.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type
6.2.1 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2017-2028)
6.3 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
6.3.1 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2017-2028)
6.4 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country
6.4.1 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size (2017-2028)
7.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type
7.2.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2017-2028)
7.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
7.3.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2017-2028)
7.4 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country
7.4.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size (2017-2028)
9.2 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type
9.2.1 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
9.3.1 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country
9.4.1 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Blue Earth Diagnostics
11.1.1 Blue Earth Diagnostics Company Details
11.1.2 Blue Earth Diagnostics Business Overview
11.1.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.1.4 Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.1.5 Blue Earth Diagnostics Recent Developments
11.2 PETNET Solutions
11.2.1 PETNET Solutions Company Details
11.2.2 PETNET Solutions Business Overview
11.2.3 PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.2.4 PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.2.5 PETNET Solutions Recent Developments
11.3 Cardinal Health
11.3.1 Cardinal Health Company Details
11.3.2 Cardinal Health Business Overview
11.3.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.3.4 Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.3.5 Cardinal Health Recent Developments
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Details
11.4.2 Lantheus Medical Imaging Business Overview
11.4.3 Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.4.4 Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.4.5 Lantheus Medical Imaging Recent Developments
11.5 Jubilant Pharma
11.5.1 Jubilant Pharma Company Details
11.5.2 Jubilant Pharma Business Overview
11.5.3 Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.5.4 Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.5.5 Jubilant Pharma Recent Developments
11.6 NCM-USA
11.6.1 NCM-USA Company Details
11.6.2 NCM-USA Business Overview
11.6.3 NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.6.4 NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.6.5 NCM-USA Recent Developments
11.7 Progenics Pharma
11.7.1 Progenics Pharma Company Details
11.7.2 Progenics Pharma Business Overview
11.7.3 Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.7.4 Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.7.5 Progenics Pharma Recent Developments
11.8 Telix Pharma
11.8.1 Telix Pharma Company Details
11.8.2 Telix Pharma Business Overview
11.8.3 Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.8.4 Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.8.5 Telix Pharma Recent Developments
11.9 ImaginAb
11.9.1 ImaginAb Company Details
11.9.2 ImaginAb Business Overview
11.9.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.9.4 ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.9.5 ImaginAb Recent Developments
11.10 Theragnostics
11.10.1 Theragnostics Company Details
11.10.2 Theragnostics Business Overview
11.10.3 Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.10.4 Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.10.5 Theragnostics Recent Developments
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.11.4 Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.11.5 Novartis Recent Developments
11.12 Alliance Medical
11.12.1 Alliance Medical Company Details
11.12.2 Alliance Medical Business Overview
11.12.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Introduction
11.12.4 Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
11.12.5 Alliance Medical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of SPECT
Table 3. Key Players of PET
Table 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2017-2022)
Table 8. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region (2023-2028)
Table 10. Prostate Cancer Nuclear Medicine Diagnostics Market Trends
Table 11. Prostate Cancer Nuclear Medicine Diagnostics Market Drivers
Table 12. Prostate Cancer Nuclear Medicine Diagnostics Market Challenges
Table 13. Prostate Cancer Nuclear Medicine Diagnostics Market Restraints
Table 14. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Players (2017-2022)
Table 16. Global Top Prostate Cancer Nuclear Medicine Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2021)
Table 17. Ranking of Global Top Prostate Cancer Nuclear Medicine Diagnostics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Prostate Cancer Nuclear Medicine Diagnostics Product Solution and Service
Table 21. Date of Enter into Prostate Cancer Nuclear Medicine Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Type (2017-2022)
Table 25. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Market Share by Type (2023-2028)
Table 27. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Application (2017-2022)
Table 29. Global Prostate Cancer Nuclear Medicine Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Prostate Cancer Nuclear Medicine Diagnostics Revenue Share by Application (2023-2028)
Table 31. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 61. Blue Earth Diagnostics Company Details
Table 62. Blue Earth Diagnostics Business Overview
Table 63. Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product
Table 64. Blue Earth Diagnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 65. Blue Earth Diagnostics Recent Developments
Table 66. PETNET Solutions Company Details
Table 67. PETNET Solutions Business Overview
Table 68. PETNET Solutions Prostate Cancer Nuclear Medicine Diagnostics Product
Table 69. PETNET Solutions Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 70. PETNET Solutions Recent Developments
Table 71. Cardinal Health Company Details
Table 72. Cardinal Health Business Overview
Table 73. Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product
Table 74. Cardinal Health Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 75. Cardinal Health Recent Developments
Table 76. Lantheus Medical Imaging Company Details
Table 77. Lantheus Medical Imaging Business Overview
Table 78. Lantheus Medical Imaging Prostate Cancer Nuclear Medicine Diagnostics Product
Table 79. Lantheus Medical Imaging Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 80. Lantheus Medical Imaging Recent Developments
Table 81. Jubilant Pharma Company Details
Table 82. Jubilant Pharma Business Overview
Table 83. Jubilant Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
Table 84. Jubilant Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 85. Jubilant Pharma Recent Developments
Table 86. NCM-USA Company Details
Table 87. NCM-USA Business Overview
Table 88. NCM-USA Prostate Cancer Nuclear Medicine Diagnostics Product
Table 89. NCM-USA Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 90. NCM-USA Recent Developments
Table 91. Progenics Pharma Company Details
Table 92. Progenics Pharma Business Overview
Table 93. Progenics Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
Table 94. Progenics Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 95. Progenics Pharma Recent Developments
Table 96. Telix Pharma Company Details
Table 97. Telix Pharma Business Overview
Table 98. Telix Pharma Prostate Cancer Nuclear Medicine Diagnostics Product
Table 99. Telix Pharma Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 100. Telix Pharma Recent Developments
Table 101. ImaginAb Company Details
Table 102. ImaginAb Business Overview
Table 103. ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product
Table 104. ImaginAb Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 105. ImaginAb Recent Developments
Table 106. Theragnostics Company Details
Table 107. Theragnostics Business Overview
Table 108. Theragnostics Prostate Cancer Nuclear Medicine Diagnostics Product
Table 109. Theragnostics Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 110. Theragnostics Recent Developments
Table 111. Novartis Company Details
Table 112. Novartis Business Overview
Table 113. Novartis Prostate Cancer Nuclear Medicine Diagnostics Product
Table 114. Novartis Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 115. Novartis Recent Developments
Table 116. Alliance Medical Company Details
Table 117. Alliance Medical Business Overview
Table 118. Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product
Table 119. Alliance Medical Revenue in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022) & (US$ Million)
Table 120. Alliance Medical Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. SPECT Features
Figure 3. PET Features
Figure 4. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Prostate Cancer Nuclear Medicine Diagnostics Report Years Considered
Figure 9. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Prostate Cancer Nuclear Medicine Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Region: 2021 VS 2028
Figure 12. Global Prostate Cancer Nuclear Medicine Diagnostics Market Share by Players in 2021
Figure 13. Global Top Prostate Cancer Nuclear Medicine Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Nuclear Medicine Diagnostics as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Prostate Cancer Nuclear Medicine Diagnostics Revenue in 2021
Figure 15. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2028)
Figure 17. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2028)
Figure 18. North America Prostate Cancer Nuclear Medicine Diagnostics Market Size Share by Country (2017-2028)
Figure 19. United States Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2028)
Figure 23. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2028)
Figure 24. Europe Prostate Cancer Nuclear Medicine Diagnostics Market Size Share by Country (2017-2028)
Figure 25. Germany Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Size Share by Region (2017-2028)
Figure 35. China Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Prostate Cancer Nuclear Medicine Diagnostics Market Size Share by Country (2017-2028)
Figure 45. Mexico Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Size Share by Country (2017-2028)
Figure 51. Turkey Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Prostate Cancer Nuclear Medicine Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Blue Earth Diagnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 55. PETNET Solutions Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 56. Cardinal Health Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 57. Lantheus Medical Imaging Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 58. Jubilant Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 59. NCM-USA Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 60. Progenics Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 61. Telix Pharma Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 62. ImaginAb Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 63. Theragnostics Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 64. Novartis Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 65. Alliance Medical Revenue Growth Rate in Prostate Cancer Nuclear Medicine Diagnostics Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Industry Market Size
